Fruquintinib and SeRplulimab: Opening New Frontiers in Treating Non-clear Cell Renal Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Non-clear Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT05831891
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Shanghai, China
Influence of Anesthesia Methods on CTCs in TURBT Patients
Not Applicable
Not yet recruiting
- Conditions
- Bladder Cancer
- Interventions
- Procedure: General AnesthesiaProcedure: Spinal Anesthesia
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 162
- Registration Number
- NCT05824299
- Locations
- 🇨🇳
Renji Hospital affliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
Not Applicable
Recruiting
- Conditions
- Metastatic Renal Cell Carcinoma
- Interventions
- Drug: PD-1 inhibitor combined with axitinib
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05816642
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
Clinical Study on Third-line Treatment of Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With Sindillimab
Not yet recruiting
- Conditions
- Dvanced Duodenal AdenocarcinomaFurquinelone Combined With SintilimabThird-line Treatment
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05810142
A Exploratory Trial of WTX221 in Refractory Gout Patients
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT05800041
CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Drug: CDK4/6 inhibitor
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 172
- Registration Number
- NCT05795335
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer
Phase 2
Active, not recruiting
- Conditions
- Stomach Neoplasms
- Interventions
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05795296
- Locations
- 🇨🇳
Renji Hospital, Shanghai, China
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
Not yet recruiting
- Conditions
- Gynecologic DiseaseIntestines CancerLiver CancerTraumaFractures, BonePulmonary Cancer
- First Posted Date
- 2023-03-23
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 50000
- Registration Number
- NCT05781581
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
Not Applicable
Recruiting
- Conditions
- Obesity, AbdominalDiabetes Mellitus, Type 2Abdominal FatNon-Alcoholic Fatty Liver DiseaseMetforminMetabolism Disorder, GlucoseMetabolism Disorder, Lipid
- Interventions
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05779644
- Locations
- 🇨🇳
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Safety and Efficacy of Therapeutic Hypothermia in Acute Ischemic Stroke
Not Applicable
Not yet recruiting
- Conditions
- Stroke, Ischemic
- Interventions
- Procedure: Therapeutic hypothermia
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 252
- Registration Number
- NCT05779176
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath